GLP-3 "RET" · 60MG
60MG research vial of retatrutide-class tri-agonist peptide for extended, high-volume metabolic pathway investigation.
These products are sold strictly for in-vitro laboratory research and are not intended for human consumption, diagnosis, treatment, or any therapeutic use. Purchaser must be 18 years of age or older and confirms they are a qualified researcher.
Product Information
Research DatasheetProduct Overview
Retatrutide is a synthetic investigational peptide designed as a triple receptor agonist targeting the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. It is widely studied in laboratory settings to investigate metabolic signaling, energy homeostasis, glucose regulation, lipid metabolism, and receptor pharmacology. This lyophilized research peptide is manufactured under sterile conditions and undergoes third-party analytical testing for identity and purity. For laboratory research use only. Not for human or veterinary use.
Molecular Profile
Research Applications
- ◆Triple incretin receptor pharmacology
- ◆Metabolic signaling pathway research
- ◆Glucose homeostasis investigations
- ◆Energy expenditure studies
- ◆Lipid metabolism research
- ◆Endocrine signaling investigations
- ◆Receptor binding and activation studies
- ◆Obesity and metabolic disease laboratory models
- ◆Peptide pharmacokinetics and stability research
- ◆Drug discovery and translational peptide research
Quality Standards
For in-vitro research use only. Not for human consumption, diagnosis, or treatment.
60MG research vial of retatrutide-class tri-agonist peptide for extended, high-volume metabolic pathway investigation. All ENOS research vials are lyophilized, sealed under sterile conditions, and shipped with cold-chain packaging where appropriate. A downloadable Certificate of Analysis is available on request for every batch.
You may also like
GLP-3 "RET"
GLP-3 "RET" · 10MG
Next-gen tri-agonist studied for metabolic modulation.
